David W. Wareham

5.6k total citations · 1 hit paper
103 papers, 4.2k citations indexed

About

David W. Wareham is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, David W. Wareham has authored 103 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Medicine, 34 papers in Endocrinology and 30 papers in Epidemiology. Recurrent topics in David W. Wareham's work include Antibiotic Resistance in Bacteria (72 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pharmaceutical and Antibiotic Environmental Impacts (16 papers). David W. Wareham is often cited by papers focused on Antibiotic Resistance in Bacteria (72 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pharmaceutical and Antibiotic Environmental Impacts (16 papers). David W. Wareham collaborates with scholars based in United Kingdom, Australia and Netherlands. David W. Wareham's co-authors include N Claire Gordon, Michael Hornsey, Lynette Phee, Neil Woodford, Jonathan W. Betts, David C. Bean, D. Krahé, Christopher Teale, Michel Doumith and Beatriz Guerra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

David W. Wareham

101 papers receiving 4.1k citations

Hit Papers

Antimicrobial activity of the green tea polyphenol (−)-ep... 2010 2026 2015 2020 2010 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia
    2010 119 citations N Claire Gordon, David W. Wareham International Journal of Antimicrobial Agents profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Wareham United Kingdom 38 2.9k 1.1k 1.1k 963 889 103 4.2k
Hanna E. Sidjabat Australia 38 3.2k 1.1× 1.7k 1.5× 742 0.7× 774 0.8× 1.0k 1.1× 91 4.1k
Ørjan Samuelsen Norway 35 3.1k 1.1× 1.4k 1.3× 765 0.7× 1.1k 1.1× 638 0.7× 95 4.0k
Francesco Luzzaro Italy 34 3.5k 1.2× 1.5k 1.3× 826 0.8× 939 1.0× 1.1k 1.2× 112 4.3k
Yan Jiang China 35 2.8k 1.0× 1.1k 1.0× 637 0.6× 1.0k 1.1× 632 0.7× 149 3.8k
José Manuel Rodríguez-Martínez Spain 33 2.9k 1.0× 980 0.9× 1.0k 1.0× 922 1.0× 706 0.8× 96 3.5k
Alejandro Beceiro Spain 29 2.8k 1.0× 1.1k 1.0× 805 0.8× 1.4k 1.4× 560 0.6× 94 3.8k
D. M. Livermore United Kingdom 22 3.7k 1.3× 1.3k 1.2× 1.2k 1.1× 1.2k 1.3× 1.0k 1.2× 25 4.8k
Fupin Hu China 35 2.8k 1.0× 939 0.8× 1.1k 1.0× 905 0.9× 931 1.0× 166 4.4k
Raffaele Zarrilli Italy 46 3.2k 1.1× 1.7k 1.5× 1.1k 1.0× 1.8k 1.9× 826 0.9× 111 5.7k
Antonio Doménech‐Sánchez Spain 19 2.5k 0.9× 1.1k 1.0× 731 0.7× 801 0.8× 455 0.5× 46 3.1k

Countries citing papers authored by David W. Wareham

Since Specialization
Citations

This map shows the geographic impact of David W. Wareham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Wareham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Wareham more than expected).

Fields of papers citing papers by David W. Wareham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Wareham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Wareham. The network helps show where David W. Wareham may publish in the future.

Co-authorship network of co-authors of David W. Wareham

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Wareham. A scholar is included among the top collaborators of David W. Wareham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Wareham. David W. Wareham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wareham, David W., et al.. (2024). Aeromonas and mcr–3: A Critical Juncture for Transferable Polymyxin Resistance in Gram-Negative Bacteria. Pathogens. 13(11). 921–921. 2 indexed citations
2.
Ledda, Alice, Liam P. Shaw, Elita Jauneikaite, et al.. (2022). Hospital outbreak of carbapenem-resistant Enterobacterales associated with a bla OXA-48 plasmid carried mostly by Escherichia coli ST399. Microbial Genomics. 8(4). 9 indexed citations
3.
Bean, David C. & David W. Wareham. (2022). Draft genome sequence of a multidrug-resistant Pseudomonas aeruginosa producing blaSIM metallo-β-lactamase: London, UK. Journal of Global Antimicrobial Resistance. 29. 222–224. 4 indexed citations
4.
5.
Hornsey, Michael & David W. Wareham. (2018). Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii. Scientific Reports. 8(1). 4234–4234. 10 indexed citations
6.
Tängdén, Thomas, Véronique Martin, Tim Felton, et al.. (2017). The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Medicine. 43(7). 1021–1032. 89 indexed citations
7.
8.
Millar, Michael, Jane F. Turton, Mark Wilks, et al.. (2016). ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producingEscherichia coliin units or networks: Table 1.. Journal of Antimicrobial Chemotherapy. 71(5). 1174–1177. 2 indexed citations
9.
Personne, Yoann, Michael A. Curtis, David W. Wareham, & Richard Waite. (2014). Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. Journal of Antimicrobial Chemotherapy. 69(12). 3236–3243. 15 indexed citations
10.
Hornsey, Michael, Lynette Phee, Neil Woodford, et al.. (2013). Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. Journal of Clinical Pathology. 66(4). 348–350. 29 indexed citations
11.
Hornsey, Michael, et al.. (2013). In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. International Journal of Antimicrobial Agents. 42(4). 343–346. 24 indexed citations
12.
Hornsey, Michael & David W. Wareham. (2011). In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection. Antimicrobial Agents and Chemotherapy. 55(7). 3534–3537. 101 indexed citations
13.
Gordon, N Claire, et al.. (2010). Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 54(12). 5316–5322. 167 indexed citations
14.
Wareham, David W. & David C. Bean. (2010). Molecular typing of multi-drug resistant Acinetobacter baumannii from London hospitals. International Journal of Infectious Diseases. 14. e36–e36. 1 indexed citations
15.
Hornsey, Michael, Matthew J. Ellington, Michel Doumith, et al.. (2010). AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 65(8). 1589–1593. 122 indexed citations
16.
Bean, David C., D. Krahé, & David W. Wareham. (2008). Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006. Annals of Clinical Microbiology and Antimicrobials. 7(1). 13–13. 136 indexed citations
17.
Wareham, David W., et al.. (2008). Tackling antibiotic resistance: a dose of common antisense?. Journal of Antimicrobial Chemotherapy. 63(2). 225–229. 47 indexed citations
18.
Wareham, David W. & Michael A. Curtis. (2007). A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. International Journal of Medical Microbiology. 297(4). 227–234. 43 indexed citations
19.
20.
Das, Satya, Anne V. Hall, David W. Wareham, & K. E. Britton. (2002). Infection imaging with radiopharmaceuticals in the 21st century. Brazilian Archives of Biology and Technology. 45(spe). 25–37. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanna E. Sidjabat Breakdown of academic impact, for papers by Ørjan Samuelsen Breakdown of academic impact, for papers by Francesco Luzzaro Breakdown of academic impact, for papers by Yan Jiang Breakdown of academic impact, for papers by José Manuel Rodríguez-Martínez Breakdown of academic impact, for papers by Alejandro Beceiro Breakdown of academic impact, for papers by D. M. Livermore Breakdown of academic impact, for papers by Fupin Hu Breakdown of academic impact, for papers by Raffaele Zarrilli Breakdown of academic impact, for papers by Antonio Doménech‐Sánchez
Rankless by CCL
2026